.. .. Références,

.. .. Serment-d'hippocrate, Eur J Cancer Prev, vol.23, pp.449-57, 2000.

J. Maris and C. Denny, Focus on embryonal malignancies, Cancer Cell, vol.2, pp.447-50, 2002.

B. Strahm and D. Malkin, Hereditary cancer predisposition in children: Genetic basis and clinical implications, Int.J.Cancer, 2001.

A. G. Knudson, Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci, vol.68, pp.820-823, 1971.

J. M. Horowitz, Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumor cells, Proc. Natl. Acad. Sci, vol.87, pp.2775-2779, 1990.

J. Varley, D. Evans, and J. Birch, Li-Fraumeni syndrome-a molecular and clinical review, Br. J. Cancer, vol.76, pp.1-14, 1997.

M. Hisada, J. E. Garber, F. P. Li, C. Y. Fung, and J. F. Fraumeni, Multiple primary cancers in families with Li-Fraumeni syndrome, JNCI J. Natl. Cancer Inst, vol.90, pp.606-611, 1998.

J. M. Nigro and S. J. Baker, Mutations in the p53 gene occur in diverse human tumour types, Nature, vol.342, pp.705-708, 1989.

W. Foulkes and A. Bahubeshi, Extending the phenotypes associated with DICER1 mutations, Hum Mutat, vol.32, pp.1381-1385, 2011.

D. A. Hill, DICER1 Mutations in Familial Pleuropulmonary Blastoma, Science, vol.325, pp.965-965, 2009.

F. Bourdeaut, Frequent hSNF5/INI1 Germline Mutations in Patients with

, Rhabdoid Tumor. Clin. Cancer Res, vol.17, pp.31-38, 2011.

X. Wang, J. R. Haswell, and C. W. Roberts, Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer-Mechanisms and Potential Therapeutic Insights, Clin. Cancer Res, vol.20, pp.21-27, 2014.

S. A. Narod, M. M. Hawkins, C. M. Robertson, and C. A. Stiller, Congenital anomalies and childhood cancer in Great Britain, Am. J. Hum. Genet, vol.60, p.474, 1997.

A. E. Altmann, J. L. Halliday, and G. G. Giles, Associations between congenital malformations and childhood cancer. A register-based case-control study, Br. J. Cancer, vol.78, p.1244, 1998.

M. Nishi, H. Miyake, and T. Takeda, Congenital malformations and childhood cancer, Med Pediatr Oncol, vol.34, pp.250-254, 2000.

J. H. Merks, H. N. Caron, and R. C. Hennekam, High incidence of malformation syndromes in a series of 1,073 children with cancer, Am. J. Med. Genet. A, vol.134, pp.132-143, 2005.

M. M. Agha, Congenital abnormalities and childhood cancer: A cohort record-linkage study, Cancer, vol.103, pp.1939-1948, 2005.

J. H. Merks, Prevalence and patterns of morphological abnormalities in patients with childhood cancer, JAMA, vol.299, pp.61-69, 2008.

S. E. Carozza, P. H. Langlois, E. A. Miller, and M. Canfield, Are Children With Birth Defects at Higher Risk of Childhood Cancers?, Am. J. Epidemiol, vol.175, pp.1217-1224, 2012.

A. E. Janitz, B. R. Neas, and J. E. Campbell, Childhood cancer in children with congenital anomalies in Oklahoma, Cancer in Children with Congenital Anomalies. Birt. Defects Res. A. Clin. Mol. Teratol, vol.106, pp.633-642, 1997.

A. J. Buckler, J. Pelletier, D. A. Haber, T. Glaser, and D. E. Housman, Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development, Mol. Cell. Biol, vol.11, pp.1707-1712, 1991.

D. Haber and A. Buckler, WT1 a novel tumor suppressor gene inactivated in Wilms' tumor, New Biol, vol.4, pp.97-106, 1992.

C. Nava and N. Hanna, Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RASMAPK signalling pathway genotype-phenotype relationships and overlap with Costello syndrome, J. Med. Genet, vol.44, pp.763-771, 2007.

K. Gripp, Tumor predisposition in Costello syndrom, Am. J. Med. Genet, vol.15, pp.72-79, 2005.

S. Martinelli and H. Mcdowell, RAS signaling dysregulation in human embryonal Rhabdomyosarcoma, Genes. Chromosomes Cancer, vol.48, pp.975-982, 2009.

B. Vogelstein and K. Kinzler, Cancer genes and the pathways they control, Nat. Med, vol.10, pp.789-799, 2004.

J. Dexheimer, B. Scheid, A. Babaoff, S. Martens, and S. Kennebeck, Preparing for International Classification of Diseases, 10th Revision, Clinical Modification implementation: strategies for maintaining an efficient workflow, Pediatr Emerg Care, vol.31, pp.65-74, 2015.

E. Steliarova-foucher, C. Stiller, B. Lacour, and P. Kaatsch, International Classification of Childhood Cancer, Cancer, vol.103, pp.1457-1467, 2005.

I. A. Van-rooij, L. F. Van-der-zanden, and E. M. Bongers,

, AGORA, a Data and Biobank for Birth Defects and Childhood Cancer, Birth Defects Research, 2016.

F. Mili, M. Khoury, and W. Flanders, Risk of childhood cancer for infants with birth defects. A record-linkage study, Am J Epidemiol, vol.137, pp.629-667, 1968.

B. Vogelstein, Cancer Genome Landscapes. Science, vol.339, pp.1546-1558, 2013.

J. Chmielecki, M. Bailey, and J. He, Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra, Cancer Res, vol.77, pp.509-519, 2017.

T. Bjorge, S. Cnattingius, R. T. Lie, S. Tretli, and A. Engeland, Cancer Risk in Children with Birth Defects and in Their Families: A Population Based Cohort Study of 5.2 Million Children from Norway and Sweden, Cancer Epidemiol. Biomarkers Prev, vol.17, pp.500-506, 2008.

P. De-blank, M. Fisher, and G. Liu, Optic Pathway Gliomas in Neurofibromatosis

, An Update Surveillance, Treatment Indications, and Biomarkers of vision, J Neuroophtalmol, vol.37, 2017.

A. Guha, Ras activation in astrocytomas and neurofibromas, Can J Neurol Sci, vol.25, pp.267-281, 1998.

F. Brioude, A. Lacoste, and I. Netchine, Beckwith-Wiedemann Syndrome: Growth Pattern and Tumor Risk according to Molecular Mechanism, and Guidelines for Tumor Surveillance, Horm. Res. Paediatr, vol.80, pp.457-465, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00991088

S. Dumoucel, M. Gauthier-villars, and D. Stoppa-lyonnet, Malformations, genetic abnormalities and Wilms Tumors. Pediatr, Blood Cancer, vol.61, pp.140-144, 2014.

I. Magalhaes, A. Splendore, and M. Emerenciano, GATA1 mutations in acute leukemia in children with Down syndrome-Cancer Genetics and Cytogenetics, Cancer Genet Cytogenet, vol.166, pp.112-118, 2006.

D. Satgé, A. Sasco, and N. Carlsen, A Lack of neuroblastoma in Down syndrome: a study from 11 European countries, Cancer Res, vol.58, pp.448-52, 1998.

J. R. Wong-siegel, Congenital neurodevelopmental anomalies in pediatric and young adult cancer, Am. J. Med. Genet. A, vol.173, pp.2670-2679, 2017.

K. J. Johnson, J. M. Lee, and K. Ahsan, Pediatric cancer risk in association with birth defects: A systematic review, PLOS ONE, vol.12, p.181246, 2017.

N. Breslow and J. Beckwith, Epidemiological features of Wilms' tumor results of the National Wilms' Tumor Study, J Natl Cancer Inst, vol.68, pp.429-436, 1982.

O. M. Martínez-estrada, L. A. Lettice, and A. Essafi, Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and Ecadherin, Nat. Genet, vol.42, pp.89-93, 2010.

O. Oberlin and J. Habrand, Ewing's sarcoma: towards a common protocol for adults and children, Cancer Radiother, vol.4, pp.141-144, 2000.

O. Feugeas, N. Guriec, and A. Babin-boilletot, Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma, J Clin Oncol, vol.14, pp.467-472, 1996.

C. Miller, A. Aslo, and A. Won, Alterations of the p53, Rb and MDM2 genes in osteosarcoma, J Cancer Res Clin Oncol, vol.122, pp.559-565, 1996.

T. C. Pansuriya, Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome, Nat. Genet, vol.43, pp.1256-1261, 2011.

F. Bourdeaut and A. Hérault, Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma, J. Med. Genet, vol.47, pp.859-862, 2010.

B. Lacour, Incidence of childhood cancer in France: National Children Cancer Registries, Références bibliographiques 1, vol.19, pp.173-81, 2000.

E. Desandes, B. Lacour, and A. Belot, Cancer incidence and survival in adolescents and young adults in France, Pediatr Hematol Oncol, vol.30, pp.291-306, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00487242

J. Maris and C. Denny, Focus on embryonal malignancies, Cancer Cell, vol.2, pp.447-50, 2002.

B. Lacour, S. Goujon, and S. Guissou, Childhood cancer survival in France, 2000.

, Eur J Cancer Prev, vol.23, pp.449-57, 2014.

G. M. Marshall, D. R. Carter, and B. B. Cheung, The prenatal origins of cancer

, Rev. Cancer, vol.14, pp.277-289, 2014.

G. Re, D. Hazen-martin, D. Sens, A. Garvin, and . Nephroblastoma, Wilms' tumor): a model system of aberrant renal development, Sem Diag Path, vol.11, pp.126-135, 1994.

J. Stocker and . Hepatoblastoma, Sem Diag Path, vol.11, pp.136-143, 1994.

B. Vogelstein and K. Kinzler, Cancer genes and the pathways they control, Nat. Med, vol.10, pp.789-799, 2004.

K. Kinzler and B. Vogelstein, Gatekeepers and caretakers, Nature, vol.386, pp.761-762, 1997.

A. G. Knudson, Mutation and cancer: statistical study of retinoblastoma, Proc. Natl

. Acad and . Sci, , vol.68, pp.820-823, 1971.

B. Strahm and D. Malkin, Hereditary cancer predisposition in children: Genetic basis and clinical implications, Int.J.Cancer, 2001.

E. Cardis, G. Howe, and E. Ron, Cancer consequences of the Chernobyl accident: 20 years on, J. Radiol. Prot, vol.26, pp.127-140, 2006.

M. J. Gardner, Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria, Bmj, vol.300, pp.423-429, 1990.

R. Doll, The Seascale cluster: a probable explanation, Br. J. Cancer, vol.81, p.3, 1999.

E. Hatch, J. Palmer, and L. Titus-ernstoff, Cancer risk in women exposed to diethylstilbestrol in utero, JAMA, vol.280, pp.630-634, 1998.

J. Rudant, F. Menegaux, and G. Leverger, Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE), Environ. Health Perspect, vol.115, pp.1787-1793, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00250367

J. M. God and A. Haque, Burkitt Lymphoma: Pathogenesis and Immune Evasion

. Oncol, , pp.1-14, 2010.

M. Greaves, Aetiology of acute leukaemia, Lancet, vol.349, pp.344-349, 1997.

R. Ajrouche, J. Rudant, and L. Orsi, Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE), Br. J. Cancer, vol.112, pp.1017-1026, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01143257

L. Kinlen, M. Dickson, and C. Stiller, Childhood leukaemia and non-Hodgkin's lymphoma near large rural construction sites, with a comparison with Seliafield nuclear site, Bmj, vol.310, pp.763-768, 1995.

K. Dziurzynski, S. M. Chang, and A. B. Heimberger, & the HCMV and Gliomas Symposium. Consensus on the role of human cytomegalovirus in glioblastoma, Neuro-Oncol, vol.14, pp.246-255, 2012.

J. Zhang, Germline Mutations in Predisposition Genes in Pediatric Cancer

. Engl, J. Med, vol.373, pp.2336-2346, 2015.

J. M. Horowitz, Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells, Proc. Natl. Acad. Sci, vol.87, pp.2775-2779, 1990.

A. Knudson, Antioncogenes and human cancer, Proc. Natl. Acad. Sci. USA, vol.90, pp.10914-10921, 1993.

G. Bougeard, Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

, J. Clin. Oncol, vol.33, pp.2345-2352, 2015.

J. Varley, D. Evans, and J. Birch, Li-Fraumeni syndrome-a molecular and clinical review, Br. J. Cancer, vol.76, pp.1-14, 1997.

J. M. Nigro and S. J. Baker, Mutations in the p53 gene occur in diverse human tumour types, Nature, vol.342, pp.705-708, 1989.

A. Giaccia and M. Kastan, The complexity of p53 modulation: emerging patterns from divergent signals, Genes Dev, vol.12, pp.2973-2983, 1998.

K. Wimmer and C. P. Kratz, Constitutional mismatch repair-deficiency syndrome
URL : https://hal.archives-ouvertes.fr/hal-00552674

, Haematologica, vol.95, pp.699-701, 2010.

N. Lavoine, C. Colas, and M. Muleris, Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort, J. Med. Genet, vol.52, pp.770-778, 2015.

K. Wimmer, C. P. Kratz, and H. F. Vasen, Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'Care for CMMRD, J. Med. Genet, vol.51, pp.355-365, 2014.

W. Foulkes and A. Bahubeshi, Extending the phenotypes associated with DICER1 mutations, Hum Mutat, vol.32, pp.1381-1385, 2011.

D. A. Hill, DICER1 Mutations in Familial Pleuropulmonary Blastoma, Science, vol.325, pp.965-965, 2009.

I. Slade, C. Bacchelli, and H. Davies, DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome, J. Med. Genet, vol.48, pp.273-278, 2011.

M. D. Taylor, L. Liu, and C. Raffel, Mutations in SUFU predispose to medulloblastoma, Nat. Genet, vol.31, pp.306-310, 2002.

L. Brugieres, G. Pierron, and A. Chompret, Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations, J. Med. Genet, vol.47, pp.142-144, 2010.

F. Bourdeaut, Frequent hSNF5/INI1 Germline Mutations in Patients with

, Rhabdoid Tumor. Clin. Cancer Res, vol.17, pp.31-38, 2011.

X. Wang, J. R. Haswell, and C. W. Roberts, Molecular Pathways: SWI/SNF (BAF)

, Complexes Are Frequently Mutated in Cancer-Mechanisms and Potential Therapeutic Insights, Clin. Cancer Res, vol.20, pp.21-27, 2014.

S. A. Narod, M. M. Hawkins, C. M. Robertson, and C. A. Stiller, Congenital anomalies and childhood cancer in Great Britain, Am. J. Hum. Genet, vol.60, p.474, 1997.

A. E. Altmann, J. L. Halliday, and G. G. Giles, Associations between congenital malformations and childhood cancer. A register-based case-control study, Br. J. Cancer, vol.78, p.1244, 1998.

M. Nishi, H. Miyake, and T. Takeda, Congenital malformations and childhood cancer

, Med Pediatr Oncol, vol.34, pp.250-254, 2000.

J. H. Merks, H. N. Caron, and R. C. Hennekam, High incidence of malformation syndromes in a series of 1,073 children with cancer, Am. J. Med. Genet. A, vol.134, pp.132-143, 2005.

M. M. Agha, Congenital abnormalities and childhood cancer: A cohort recordlinkage study, Cancer, vol.103, pp.1939-1948, 2005.

J. H. Merks, Prevalence and patterns of morphological abnormalities in patients with childhood cancer, JAMA, vol.299, pp.61-69, 2008.

S. E. Carozza, P. H. Langlois, E. A. Miller, and M. Canfield, Are Children With Birth Defects at Higher Risk of Childhood Cancers?, Am. J. Epidemiol, vol.175, pp.1217-1224, 2012.

A. E. Janitz, B. R. Neas, and J. E. Campbell, Childhood cancer in children with congenital anomalies in Oklahoma, Cancer in Children with Congenital Anomalies. Birt. Defects Res. A. Clin. Mol. Teratol, vol.106, pp.633-642, 1997.

V. Riccardi and E. Sujansky, Chromosomal imbalance in the Aniridia-Wilms'Tumor Association: 11p Interstitial Deletion, Pediatrics, vol.61, 1978.

A. J. Buckler, J. Pelletier, D. A. Haber, T. Glaser, and D. E. Housman, Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development, Mol. Cell. Biol, vol.11, pp.1707-1712, 1991.

D. Haber and A. Buckler, WT1 a novel tumor suppressor gene inactivated in Wilms' tumor, New Biol, vol.4, pp.97-106, 1992.

C. Nava and N. Hanna, Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RASMAPK signalling pathway genotype-phenotype relationships and overlap with Costello syndrome, J. Med. Genet, vol.44, pp.763-771, 2007.

K. Gripp, Tumor predisposition in Costello syndrom, Am. J. Med. Genet, vol.15, pp.72-79, 2005.

S. Martinelli and H. Mcdowell, RAS signaling dysregulation in human embryonal

. Rhabdomyosarcoma, Genes. Chromosomes Cancer, vol.48, pp.975-982, 2009.

M. Bentires-alij, J. Paez, and F. David, Activating Mutations of the Noonan Syndrome-Associated SHP2PTPN11 Gene in Human Solid Tumors and Adult acute myelogenous Leukemia, Cancer Res, vol.64, pp.8816-8836, 2004.

E. Steliarova-foucher, C. Stiller, B. Lacour, and P. Kaatsch, International Classification of Childhood Cancer, Cancer, vol.103, pp.1457-1467, 2005.

P. J. Scotting, D. A. Walker, and G. Perilongo, Childhood solid tumours: a developmental disorder, Nat. Rev. Cancer, vol.5, p.481, 2005.

B. Vogelstein, Cancer Genome Landscapes. Science, vol.339, pp.1546-1558, 2013.

J. Chmielecki, M. Bailey, and J. He, Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra, Cancer Res, vol.77, pp.509-519, 2017.

R. Listernick, J. Charrow, M. Greenwald, and N. Esterly, Optic gliomas in children with neurofibromatosis type 1, J Pediatr, vol.114, pp.788-792, 1989.

A. Guha, Ras activation in astrocytomas and neurofibromas, Can J Neurol Sci, vol.25, pp.267-281, 1998.

F. Brioude, A. Lacoste, and I. Netchine, Beckwith-Wiedemann Syndrome: Growth Pattern and Tumor Risk according to Molecular Mechanism, and Guidelines for Tumor Surveillance, Horm. Res. Paediatr, vol.80, pp.457-465, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00991088

S. Dumoucel, M. Gauthier-villars, and D. Stoppa-lyonnet, Malformations, genetic abnormalities and Wilms Tumors. Pediatr, Blood Cancer, vol.61, pp.140-144, 2014.

I. Magalhaes, A. Splendore, and M. Emerenciano, GATA1 mutations in acute leukemia in children with Down syndrome-Cancer Genetics and Cytogenetics, Cancer Genet Cytogenet, vol.166, pp.112-118, 2006.

D. Satgé, A. Sasco, and N. Carlsen, A Lack of neuroblastoma in Down syndrome: a study from 11 European countries, Cancer Res, vol.58, pp.448-52, 1998.

H. Hasle, I. Clemmensen, and M. Mikkelsen, Risks of leukaemia and solid tumours in individuals with Down's syndrome, Lancet, vol.15, pp.165-169, 2000.

I. Matsui, M. Tanimura, and N. Kobayashi, Neurofibromatosis type 1 and childhood cancer, Cancer, vol.72, pp.2746-2754, 1993.

I. Pollack and J. Mulvihill, Special issues in the management of gliomas in children with neurofibromatosis 1, J Neurooncol, vol.28, pp.257-268, 1996.

R. Listernick, J. Charrow, M. Greenwald, and M. Mets, Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study, J Pediatr, vol.125, pp.63-66, 1994.

J. R. Wong-siegel, Congenital neurodevelopmental anomalies in pediatric and young adult cancer, Am. J. Med. Genet. A, vol.173, pp.2670-2679, 2017.

F. Mili, C. Lynch, and M. Khoury, Risk of childhood cancer for infants with birth defects. A record linkage study, Iowa 1983-1989, Am J Epidemiol, vol.137, pp.639-683, 1993.

R. Schumacher, A. Mai, and P. Gutjahr, Association of rib anomalies and malignancy in childhood, Eur J Pediatr, vol.151, pp.432-434, 1992.

J. Merks, A. Smets, and R. Van-rijn, Prevalence of rib anomalies in normal Caucasian children and childhood cancer patients, Eur J Med Genet, vol.48, pp.113-129, 2005.

H. Zierhut, M. Murati, T. Holm, E. Hoggard, and L. G. Spector, Association of rib anomalies and childhood cancers, Br. J. Cancer, vol.105, pp.1392-1395, 2011.

N. Breslow and J. Beckwith, Epidemiological features of Wilms' tumor results of the National Wilms' Tumor Study, J Natl Cancer Inst, vol.68, pp.429-436, 1982.

O. M. Martínez-estrada, L. A. Lettice, and A. Essafi, Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin, Nat. Genet, vol.42, pp.89-93, 2010.

K. J. Johnson, J. M. Lee, and K. Ahsan, Pediatric cancer risk in association with birth defects: A systematic review, PLOS ONE, 2017.

H. Shimada, I. Ambros, and L. Dehner, The International Neuroblastoma Pathology Classification (the Shimada system), Cancer, vol.86, pp.364-372, 1999.

O. Oberlin and J. Habrand, Ewing's sarcoma: towards a common protocol for adults and children, Cancer Radiother, vol.4, pp.141-144, 2000.

O. Feugeas, N. Guriec, and A. Babin-boilletot, Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma, J Clin Oncol, vol.14, pp.467-472, 1996.

C. Miller, A. Aslo, and A. Won, Alterations of the p53, Rb and MDM2 genes in osteosarcoma, J Cancer Res Clin Oncol, vol.122, pp.559-565, 1996.

C. P. Kratz, S. Rapisuwon, and H. Reed, P. S. Cancer in

C. Noonan, Am. J. Med. Genet. C Semin. Med. Genet, vol.157, pp.83-89, 2011.

A. Crucis and W. Richer, Rhabdomyosarcomas in children with neurofibromatosis type I : A national historical cohort. Pediatr, Blood Cancer, vol.62, pp.1733-1741, 2015.

A. Malric and A. Defachelles, Fanconi anemia and solid malignancies in childhood : a national retrospective study. Pediatr, Blood Cancer, vol.62, pp.463-70, 2015.

D. G. Evans, Complications of the naevoid basal cell carcinoma syndrome: results of a population based study, J. Med. Genet, vol.30, pp.460-464, 1993.

S. Shanley and J. Ratcliffe, Nevoid basal cell carcinoma syndrome : review of 118 affected individuals, Am. J. Med. Genet, vol.15, pp.282-90, 1994.

S. Hettmer, Myogenic tumors in nevoid Basal cell carcinoma syndrome

, Pediatr. Hematol. Oncol, vol.37, p.147, 2015.

J. Taeubner, T. Brozou, and N. Qin, Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations, Eur. J. Hum. Genet, vol.26, pp.137-142, 2018.

J. F. Shern, Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and FusionNegative Tumors, Cancer Discov, vol.4, pp.216-231, 2014.

H. Hahn and L. Wojnowski, Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome, Nat. Med, vol.4, pp.619-641, 1998.

T. C. Pansuriya, Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

. Genet, , vol.43, pp.1256-1261, 2011.

F. Bourdeaut and A. Hérault, Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma, J. Med. Genet, vol.47, pp.859-862, 2010.

D. Trochet and L. O'brien, PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome, Am. J. Hum. Genet, vol.76, pp.421-426, 2005.

R. Boissy and J. Nordlund, Molecular basis of congenital hypopigmentary disorders in humans a review, Pigment Cell Res, vol.10, pp.12-24, 1997.

A. Varan and H. Sen, Neurofibromatosis type 1 and malignancy in childhood

. Genet, , vol.89, pp.341-346, 2016.

Y. Tsurusaki and N. Okamoto, Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome, Nat. Genet, vol.18, pp.376-384

J. Hoyer, Haploinsufficiency of ARID1B, a Member of the SWI/SNF-A

C. Complex, Is a Frequent Cause of Intellectual Disability, Am. J. Hum

. Genet, , vol.90, pp.565-572, 2012.

M. Sausen and R. Leary, Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma, Nat. Genet, vol.45, pp.12-17, 2013.

H. Westdorp, S. Kolders, and N. Hoogerbrugge, Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome, Cancer Lett, vol.403, pp.159-164, 2017.